Abeona Therapeutics (ABEO) Other Working Capital Changes (2023 - 2026)
Abeona Therapeutics' (ABEO) quarterly Other Working Capital Changes came in at -$182000.0 in Q1 2026, up 49.72% year-on-year from -$121557.2 in Q1 2025, and down 138.56% quarter-over-quarter from $472000.0 in Q4 2025.
Abeona Therapeutics (ABEO) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Abeona Therapeutics' Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$182000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 49.72% year-over-year to -$182000.0 in Q1 2026; TTM through Mar 2026 was -$396000.0, a 71.03% increase from a year earlier, with the FY2025 full-year figure at -$576000.0, up 56.2% from the prior year.
- Other Working Capital Changes retreated to -$182000.0 in Q1 2026 per ABEO's latest filing, from $472000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.2 million in Q1 2024 and bottomed at -$915000.0 in Q4 2025.
- The 5-year median for Other Working Capital Changes is -$238000.0 (2023), against an average of -$25058.8.
- Across the five-year window, Other Working Capital Changes dropped 28.08% in 2024 and surged 226.2% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$292000.0 in 2023, then fell by 28.08% to -$374000.0 in 2024, then jumped by 226.2% to $472000.0 in 2025, then tumbled by 138.56% to -$182000.0 in 2026.
- Per Business Quant, the three latest ABEO Other Working Capital Changes figures stand at -$182000.0 (Q1 2026), $472000.0 (Q4 2025), and -$381000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -182,000.00 |
| Mar 31, 2026 | -182,000.00 |
| Mar 31, 2026 | -182,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Sep 30, 2025 | -381,000.00 |
| Sep 30, 2025 | -381,000.00 |
| Sep 30, 2025 | -381,000.00 |
| Jun 30, 2025 | -305,000.00 |
| Jun 30, 2025 | -305,000.00 |
| Jun 30, 2025 | -305,000.00 |
| Mar 31, 2025 | -362,000.00 |
| Mar 31, 2025 | -362,000.00 |
| Mar 31, 2025 | -362,000.00 |
| Dec 31, 2024 | -374,000.00 |
| Dec 31, 2024 | -374,000.00 |
| Dec 31, 2024 | -374,000.00 |
| Sep 30, 2024 | -351,000.00 |
| Sep 30, 2024 | -351,000.00 |